Target intelligence / Profile preview

Protein O-fucosyltransferase 1 (POFUT1)

Target
POFUT1
Molecular classification
Enzyme, Glycosyltransferase
01

Overview

Protein O-fucosyltransferase 1 (POFUT1) is an enzyme localized in the endoplasmic reticulum responsible for catalyzing the transfer of fucose residues from GDP-fucose to serine or threonine residues on EGF-like repeats in specific substrate proteins, most notably Notch receptors. This O-fucosylation is essential for efficient Notch signaling—a pathway fundamental for cell differentiation, proliferation, and apoptosis throughout embryonic development and adult tissue maintenance. Mutations in POFUT1 cause autosomal dominant pigmentary disorders such as Dowling-Degos disease and may contribute to oncogenesis in contexts of aberrant Notch activity, such as T-cell acute lymphoblastic leukemia. POFUT1 is the only enzyme known to catalyze this specific glycosylation modification, and it also has important chaperoning functions for proper folding and trafficking of Notch and other EGF-like domain proteins. There are currently no approved drugs that directly target POFUT1, but it is considered a therapeutic target due to its role in disease.

Other names
FUT12KIAA0180O-FucT-1O-FUTO-Fuc-TOFUCT1GDP-fucose protein O-fucosyltransferase 1peptide-O-fucosyltransferase 1o-fucosyltransferase protein
02

Mechanism of action

Inhibition of POFUT1 would block O-fucosylation of Notch and related proteins, disrupting Notch signaling; potential antitumor effect in Notch-driven cancers. No drugs with approved mechanism yet

03

Biological functions

O-fucosylation of EGF-like domainsProtein post-translational modificationNotch receptor processingSignal transductionCell fate determinationCell proliferationDifferentiationApoptosis
04

Disease associations

Pigmentary disorders (Dowling-Degos disease)Cancer (Notch-driven leukemias)Cardiovascular diseaseDevelopmental defectsMicrocephalyMuscle aging-related phenotypes
05

Safety considerations

Potential for broad tissue effects (since Notch signaling is critical in many tissues)inhibition may cause developmental defectsskin abnormalitiescardiovascular side effectshematological toxicities
06

Interacting drugs

None established (as of current knowledge). POFUT1 is a potential target in cancers involving Notch signaling but no approved drugs directly target it yet
07

Biomarkers

Mutations in POFUT1 (for Dowling-Degos disease diagnosis and research)Expression analysis in Notch-driven cancers

Beyond the preview

Go deeper on Protein O-fucosyltransferase 1 (POFUT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein O-fucosyltransferase 1 (POFUT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call